Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 121,555 | 81,126 | 43,177 | 137,545 | 101,378 |
| Depreciation Amortization | 44,839 | 30,695 | 15,111 | 49,434 | 33,696 |
| Income taxes - deferred | N/A | N/A | N/A | -12,578 | N/A |
| Accounts receivable | -24,577 | -16,522 | -23,201 | -26,086 | -30,175 |
| Other Working Capital | -5,957 | 1,370 | -7,265 | -24,209 | 2,536 |
| Other Operating Activity | 48,502 | 27,731 | 27,469 | 59,397 | 52,204 |
| Operating Cash Flow | $184,362 | $124,400 | $55,291 | $183,503 | $159,639 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 71,031 | 90,767 | 24,990 | -105,934 | -14,001 |
| PPE Investments | -28,630 | -14,837 | -8,793 | -38,166 | -28,724 |
| Net Acquisitions | -129,000 | -129,000 | N/A | -506,406 | -506,406 |
| Other Investing Activity | -2,653 | -1,596 | -960 | 1,390 | 3,064 |
| Investing Cash Flow | $-89,252 | $-54,666 | $15,237 | $-649,116 | $-546,067 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 13,565 | 4,057 | 4,082 | 845,000 | 845,000 |
| Debt Repayment | -8,148 | -8,107 | -98 | -318,658 | -268,506 |
| Common Stock Issued | -8,234 | -11,496 | -17,311 | 10,974 | 7,414 |
| Common Stock Repurchased | -43,456 | -8,498 | 0 | -58,144 | -58,144 |
| Other Financing Activity | -838 | -251 | -252 | -25,079 | -24,588 |
| Financing Cash Flow | $-47,111 | $-24,295 | $-13,579 | $454,093 | $501,176 |
| Exchange Rate Effect | -179 | -116 | -97 | -282 | -44 |
| Beginning Cash Position | 144,531 | 144,531 | 144,531 | 156,333 | 156,333 |
| End Cash Position | 192,351 | 189,854 | 201,383 | 144,531 | 271,037 |
| Net Cash Flow | $47,820 | $45,323 | $56,852 | $-11,802 | $114,704 |
| Free Cash Flow | |||||
| Operating Cash Flow | 184,362 | 124,400 | 55,291 | 183,503 | 159,639 |
| Capital Expenditure | -28,630 | -14,837 | -8,793 | -38,166 | -28,724 |
| Free Cash Flow | 155,732 | 109,563 | 46,498 | 145,337 | 130,915 |